Heron Therapeutics | Betriebsaufwand

Operating Expenses Veränderung Datum
ALKERMES USD 337.09M 41.11M 2023-09
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Amarin USD 87.51M 16.62M 2023-09
ANI Pharmaceuticals USD 124.93M 11.05M 2023-12
Arrowhead Research USD 140.1M 15.67M 2023-12
Eisai JPY 171.22B 309M 2023-09
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
Insmed USD 261.96M 35.22M 2023-12
Ligand Pharmaceuticals USD 31.56M 1.77M 2023-12
Merck USD 16.56B 6.35B 2023-12
Neurocrine Biosciences USD 357.6M 21.5M 2023-09
Pacira USD 148.08M 1.87M 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Ultragenyx Pharmaceutical USD 249.44M 6.29M 2023-12
Veracyte USD 133.71M 11.86M 2023-12
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09



Heron Therapeutics Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2024.